Composecure press release (CMPO): Q3 Non-GAAP EPS of $0.29 beats by $0.03. Non-GAAP revenue of $120.9M (+12.9% Y/Y) beats by $4.18M. Non-GAAP Pro Forma Adjusted EBITDA ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.